NCI

NIHR and MRC fund cystic fibrosis gene therapy trial

Wednesday, March 21, 2012 11:08 AM

A groundbreaking gene therapy trial for cystic fibrosis (CF) will begin in March, thanks to a $4.9 million grant from National Institute for Health Research (NIHR) and the Medical Research Council (MRC) through the Efficacy and Mechanism Evaluation program.

More... »

Oncolytics Biotech launches phase II study in prostate cancer

Tuesday, February 28, 2012 06:08 AM

Calgary, Cananda-based Oncolytics Biotech has collaborated with the NCIC Clinical Trials Group (CTG) at Queen's University in Kingston, Ontario, to conduct a randomized phase II study of Reolysin in patients with recurrent or metastatic castration resistant prostate cancer.

More... »

Trovagene names new vice president

Friday, February 17, 2012 12:46 PM

Trovagene, a developer of transrenal molecular diagnostics, has named Charlie Rodi, Ph.D., vice president and chief technology officer.

More... »

CoE launches eTACT to authenticate drugs with smartphones

Monday, February 13, 2012 03:11 PM

The Council of Europe (CoE) and its European Directorate for the Quality of Medicines & HealthCare (EDQM) have launched eTACT, an IT-based traceability service that will allow patients to check the authenticity of their medicines using smartphones or the internet.

More... »

Clinical Financial Services expands internationally

Wednesday, January 25, 2012 01:50 PM

Clinical Financial Services (CFS), a specialty service provider focused on the business and financial management of clinical trials, has expanded its global presence, opening a new office in Edinburgh, Scotland.

More... »

AstraZeneca, MRC ink collaboration giving UK academia access to 22 compounds

Monday, December 5, 2011 02:14 PM

A wide range of compounds will be made available free of charge to UK medical researchers next year, following an agreement between the Medical Research Council (MRC) and AstraZeneca. Academia will be granted access to 22 compounds, developed by AstraZeneca. Through MRC funding, UK academia will conduct studies to better understand what drives a range of diseases with a view to exploring new treatment opportunities.

More... »

Moffitt, The US Oncology Network advance cancer patient services

Thursday, October 27, 2011 12:57 PM

Moffitt Cancer Center,  the only National Cancer Institute(NCI) Comprehensive Cancer Center in Florida, and The US Oncology Network will work together to expand access to patient services in Florida. As part of both organizations’ long-term commitment to advancing the quality and science of cancer care, the two are collaborating to develop and operate community-based cancer centers throughout the state.

More... »

Australian government launches review of health and medical research

Tuesday, July 12, 2011 12:18 PM

The Australian government has issued the draft terms of reference for a strategic review of health and medical research, according to PharmaTimes.

More... »

Study brokers Interspond, Elias Research head to court over alleged trade secret violations

Monday, July 11, 2011 08:02 AM

Two trial management firms (TMOs), known more commonly in the industry as study brokers, have taken their disagreement to court.

More... »

Clinical Financial Services offers new site activation services

Tuesday, May 17, 2011 12:18 PM

Clinical Financial Services (CFS), a company that provides business and financial management solutions for clinical trials, has launched its newest offering, site activation services. This new service includes regulatory document collection and management as well as global investigator budget and contract management.  The goal of its site activation services is to streamline and automate the trial activation process and minimize financial risk for clinical trial sponsors, CROs, and investigative sites.

More... »